• 中国科技论文统计源期刊
  • 中国科技核心期刊
  • 美国CA、俄罗斯AJ收录
高级检索

TGF-β1、Smad3在哮喘患儿中的表达及维生素D辅助治疗儿童哮喘的研究

李凡, 孟令建, 刘琳, 徐艳, 武怡

李凡, 孟令建, 刘琳, 徐艳, 武怡. TGF-β1、Smad3在哮喘患儿中的表达及维生素D辅助治疗儿童哮喘的研究[J]. 徐州医科大学学报, 2024, 44(8): 593-598. DOI: 10.12467/j.issn.2096-3882.20240197
引用本文: 李凡, 孟令建, 刘琳, 徐艳, 武怡. TGF-β1、Smad3在哮喘患儿中的表达及维生素D辅助治疗儿童哮喘的研究[J]. 徐州医科大学学报, 2024, 44(8): 593-598. DOI: 10.12467/j.issn.2096-3882.20240197
LI Fan, MENG Lingjian, LIU Lin, XU Yan, WU Yi. Expression of TGF-β1 and Smad3 in children with asthma and vitamin D adjuvant treatment of children with asthma[J]. Journal of Xuzhou Medical University, 2024, 44(8): 593-598. DOI: 10.12467/j.issn.2096-3882.20240197
Citation: LI Fan, MENG Lingjian, LIU Lin, XU Yan, WU Yi. Expression of TGF-β1 and Smad3 in children with asthma and vitamin D adjuvant treatment of children with asthma[J]. Journal of Xuzhou Medical University, 2024, 44(8): 593-598. DOI: 10.12467/j.issn.2096-3882.20240197

TGF-β1、Smad3在哮喘患儿中的表达及维生素D辅助治疗儿童哮喘的研究

基金项目: 

江苏省妇幼健康项目(F201743)

详细信息
    通讯作者:

    孟令建,E-mail:187363307@qq.com

  • 中图分类号: R72

Expression of TGF-β1 and Smad3 in children with asthma and vitamin D adjuvant treatment of children with asthma

  • 摘要: 目的 探讨转化生长因子β1(TGF-β1)、Smad3在哮喘患儿中的表达及维生素D辅助治疗儿童哮喘的疗效。方法 选取2022年4月—2023年6月于徐州医科大学附属医院就诊的120例轻度持续期哮喘患儿作为哮喘组,另取同期该院体检的80例健康儿童作为对照组。比较2组儿童血清TGF-β1、Smad3的表达水平。按照随机数字表法将哮喘组分为A组和B组,每组60例。比较A、B组患儿在治疗前、治疗1个月及3个月血清25(OH)D、TGF-β1、Smad3、呼出气一氧化氮(FeNO)、肺功能、呼吸道感染次数、哮喘急性发作次数及儿童哮喘控制测试(C-ACT)评分。结果 哮喘组TGF-β1、Smad3表达水平高于对照组,差异有统计学意义(P<0.05)。B组治疗3个月呼吸道感染次数、哮喘急性发作次数较A组明显减少,C-ACT评分较较A组升高(P<0.05)。治疗1个月、3个月,A、B两组患儿血清TGF-β1、Smad3及FeNO水平较治疗前下降(P<0.05),第1秒用力呼气量占预计值百分比(FEV1%)、呼气流速峰值占预计值百分比(PEF%)、用力呼50%肺活量的瞬间流量占预计值百分比(FEF50%)、 用力呼75%肺活量的瞬间流量占预计值百分比(FEF75%)、最大呼气中期流量占预计值百分比(MMEF75/25%)较治疗前升高(P<0.05),且同时间点A、B组比较差异有统计学意义(P<0.05)。结论 轻度持续期哮喘患儿血清TGF-β1、Smad3水平明显增高。在单纯吸入性糖皮质激素治疗下加用维生素D可降低TGF-β1、Smad3的表达水平,同时减少哮喘急性发作次数,减轻气道炎症,改善肺功能,进一步提高临床治疗效果。
    Abstract: Objective To explore the expression of transforming growth factor β1 (TGF-β1) and Smad3 in children with asthma and the efficacy of vitamin D as an adjunct therapy in the treatment of pediatric asthma. Methods A total of 120 children with mild persistent asthma, who were treated at the Affiliated Hospital of Xuzhou Medical University from April 2022 to June 2023, were selected as an asthma group. Additionally, 80 healthy children undergoing physical examinations during the same period at the hospital were selected as a control group. The serum levels of TGF-β1 and Smad3 were compared between the two groups. According to the random number table method, the asthma group was divided into group A and group B (n=60). The serum levels of 25(OH)D, TGF-β1, Smad3, fractional exhaled nitric oxide (FeNO), lung function, frequency of respiratory infections, frequency of acute asthma exacerbations, and Childhood Asthma Control Test (C-ACT) scores were compared between groups A and B before treatment, and at 1 month and 3 months after treatment. Results The levels of TGF-β1 and Smad3 in the asthma group were significantly higher than those in the control group (P<0.05). After 3 months of treatment, group B showed a significant reduction in the frequency of respiratory infections and acute asthma exacerbations, and increased C-ACT scores compared with group A (P<0.05). At 1 month and 3 months after treatment, the levels of serum TGF-β1, Smad3, and FeNO in both groups decreased compared with those before treatment (P<0.05). The percentage of predicted forced expiratory volume in the first second (FEV1%), peak expiratory flow (PEF%), forced expiratory flow at 50% of forced vital capacity (FEF50%), forced expiratory flow at 75% of forced vital capacity (FEF75%), and maximum mid-expiratory flow (MMEF75/25%) increased compared with those before treatment (P<0.05), with greater improvements observed in group B than in group A (P<0.05). Conclusions The levels of serum TGF-β1 and Smad3 are significantly elevated in children with mild persistent asthma. The addition of vitamin D to standard inhaled corticosteroid treatment can reduce the expression of TGF-β1 and Smad3, decrease the frequency of acute asthma exacerbations, alleviate airway inflammation, and improve lung function, thereby enhancing clinical therapeutic efficacy.
  • [1]

    Britt RD Jr, Ruwanpathirana A, Ford ML, et al.Macrophages orchestrate airway inflammation, remodeling, and resolution in asthma[J].Int J Mol Sci, 2023, 24(13):10451.

    [2] 刘健.支气管哮喘气道重塑机制的研究进展 [J].中国现代医学杂志, 2022, 32(12):51-54.
    [3] 沈王丰, 肖磊, 梁小红, 等."平喘汤"通过调控TGF-β1/Smad信号通路抑制哮喘大鼠气道重塑机制研究 [J].江苏中医药, 2023, 55(1):67-72.
    [4] 张倩, 乔赟, 时宜蓉, 等.基于TGF-β1/Smad3信号通路探讨针刺抗哮喘气道重塑的作用机制 [J].中国针灸, 2023, 43(6):684-690.
    [5] 郑旭红, 方俊梅, 蒋向红.维生素D3辅助治疗儿童重症哮喘的疗效及对血清炎症细胞因子水平影响 [J].全科医学临床与教育, 2022, 20(1):42-45.
    [6] 邓曼, 李尉萌.维生素D3应用于儿童支气管哮喘的效果及其对血清半乳糖凝集素-3、25二羟维生素D3水平的影响 [J].中国药物与临床, 2022, 22(2):177-180.
    [7] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2020年版)[J].中华结核和呼吸杂志, 2020, 43(12):1023-1048.
    [8]

    Xiao YL, Zhu H, Lei JH, et al.MiR-182/Sestrin2 affects the function of asthmatic airway smooth muscle cells by the AMPK/mTOR pathway [J].J Transl Int Med, 2021, 11(3):282-293.

    [9]

    Hong J, Lee PH, Lee YG, et al.Augmented angiogenic transcription factor, SOX18, is associated with asthma exacerbation[J].J Asthma, 2021, 58(9):1143-1154.

    [10]

    Eap R, Jacques E, Semlali A, et al.Cysteinyl leukotrienes regulate TGF-β1 and collagen production by bronchial fibroblasts obtained from asthmatic subjects [J].Prostaglandins Leukot Essent Fatty Acids, 2012, 86(3):127-133.

    [11]

    Brown SD, Baxter KM, Stephenson ST, et al.Airway TGF-β1 and oxidant stress in children with severe asthma:association with airflow limitation[J].J Allergy Clin Immunol, 2012, 129(2):388-396.

    [12]

    Yao Z, Fu Y.Glycyrrhizic acid restrains airway inflammation and remodeling in asthma via the TGF-β1/Smad signaling pathway [J].Exp Ther Med, 2021, 21(5):461-461.

    [13] 顾静雯, 朴香, 傅伟, 等.疏肝平喘方通过转化生长因子-β1/Smad信号通路对哮喘小鼠免疫平衡的影响 [J].世界中医药, 2023, 18(14):1974-1978, 1985.
    [14] 次苗苗, 王文革.哮喘患儿血清TGF-β1、Smad3表达及与气道重塑的关系研究 [J].陕西医学杂志, 2015, (5):612-614.
    [15]

    Huang YM, Qiu C.Research advances in airway remodeling in asthma:a narrative review[J].Ann Transl Med, 2022, 10(18):1023.

    [16]

    Feng LL, Meng TT, Qi YY, et al.Study effect of vitamin D on the immunopathology responses of the bronchi in murine model of asthma[J].Iran J Allergy Asthma Immunol, 2021, 20(5):509-519.

    [17]

    Ma JG, Wu GJ, Xiao HL, et al.Vitamin D has an effect on airway inflammation and Th17/Treg balance in asthmatic mice [J].Kaohsiung J Med Sci, 2021, 37(12):1113-1121.

    [18] 栾军.维生素D3辅助治疗对儿童支气管哮喘的肺功能及气道炎症的改善作用研究[J].中国基层医药, 2021, 28(10):1529-1533.
    [19]

    Sobczak M, Pawliczak R.Does vitamin D work synergistically with anti-asthmatic drugs in airway remodeling?[J].Int J Mol Sci, 2022, 23(21):12798.

    [20]

    Provenzano BC, Bartholo TP, Kirk KM, et al.Use of fractional exhaled nitric oxide as a potential predictor of bronchodilator response[J].Medicine, 2023, 102(28):e34073.

    [21] 韦紫倩, 依力木古丽·阿卜杜克热木, 吴葆菁.一氧化氮参数在儿童支气管哮喘中的临床应用价值[J].新医学, 2023, 54(8):549-553.
    [22]

    Gilda V, Sebastian F, Jack P, et al.Biologics and airway remodeling in severe asthma [J].Allergy, 2022, 77(12):3538-3552.

    [23] 王俊霞, 周耀铃, 李静, 等.呼出气一氧化氮联合25-羟维生素D检测在儿童支气管哮喘诊疗中的价值 [J].中国妇幼保健, 2019, 34(11):2524-2527.
    [24] 李巧瑜.维生素D与儿童肺部疾病的关系 [J].海峡药学, 2022, 34(12):145-148.
    [25]

    Nicolae M, Mihai CM, Chisnoiu T, et al.Immunomodulatory effects of vitamin D in respiratory tract infections and COVID-19 in children[J].Nutrients, 2023, 15(15):3430.

    [26] 王润娟, 田新瑞, 常琴, 等.血清维生素D、TGF-β1水平与哮喘患者气道重塑的相关性[J].中国医师杂志, 2016, 18(12):1840-1842.
计量
  • 文章访问数:  119
  • HTML全文浏览量:  11
  • PDF下载量:  19
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-03-15
  • 修回日期:  2024-07-05

目录

    /

    返回文章
    返回